Processa Pharmaceuticals Inc (PCSA)
NASDAQ
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -56.981 | -27.87 | -79.863 | -44.228 | -156.333 | -154.397 |
Return on Equity (%) | -77.621 | -37.914 | -93.138 | -47.2 | -166.428 | -178.523 |
Return on Invested Capital (%) | -17.887 | -35.486 | -92.567 | -46.825 | -118.191 | -184.079 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | -0.042 | 1.334 | 1.109 | 0.467 | 0.203 |
Earnings Per Share | N/A | -0.087 | -1.364 | -0.727 | -1.715 | -0.452 |
Cash Per Share | N/A | 0.018 | 1.459 | 1.05 | 0.407 | 0.191 |
Working Capital Per Share | N/A | -0.005 | 1.418 | 1.104 | 0.462 | 0.199 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | -0.103 | -1.459 | -0.761 | -1.715 | -0.452 |
EBITDA Per Share | N/A | -0.103 | -1.459 | -0.761 | -1.715 | -0.452 |
Free Cash Flow Per Share | N/A | -0.108 | -1.44 | -0.777 | -1.764 | -0.451 |
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | N/A | N/A | N/A | N/A | N/A | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||
Actions en circulation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 2,23M |
Ratio cours/bénéfice | -0,2 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 0,47 |
Ratio prix/valeur comptable | 0,45 |
Rendement de dividende | - |
Actions en circulation | 3,27M |
Volume moyen (1 semaine) | 67,42k |
Volume moyen (1 mois) | 65,86k |
Variation sur 52 semaines | -77,11% |
Plus haut sur 52 semaines | 3,305 |
Plus bas sur 52 semaines | 0,65 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales